Arcturus Therapeutics Holdings Inc.ARCTNASDAQ
Loading
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q4 2025 | -116.23% |
| Q3 2025 | -46.49% |
| Q2 2025 | 34.78% |
| Q1 2025 | 53.09% |
| Q4 2024 | -334.67% |
| Q3 2024 | 59.90% |
| Q2 2024 | 35.80% |
| Q1 2024 | -129.07% |
| Q4 2023 | 27.83% |
| Q3 2023 | 69.13% |
| Q2 2023 | -203.54% |
| Q1 2023 | -56.75% |
| Q4 2022 | 432.75% |
| Q3 2022 | -63.55% |
| Q2 2022 | 57.86% |
| Q1 2022 | -32.35% |
| Q4 2021 | 28.51% |
| Q3 2021 | 0.91% |
| Q2 2021 | 3.13% |
| Q1 2021 | -81.15% |
| Q4 2020 | -48.09% |
| Q3 2020 | -104.66% |
| Q2 2020 | -4.97% |
| Q1 2020 | 11.03% |
| Q4 2019 | -47.84% |
| Q3 2019 | -985.11% |
| Q2 2019 | 90.05% |
| Q1 2019 | -580.91% |
| Q4 2018 | 76.23% |
| Q3 2018 | 57.26% |
| Q2 2018 | -51.42% |
| Q1 2018 | -478.43% |
| Q4 2017 | 55.54% |
| Q3 2017 | 30.78% |
| Q2 2017 | -4.86% |
| Q1 2017 | 40.61% |
| Q4 2016 | 24.03% |
| Q3 2016 | -34.80% |
| Q2 2016 | -13.80% |
| Q1 2016 | -4.07% |